Top Stories
The analysis is the largest to show that post-surgical MRD status may help identify which patients with resected colorectal liver metastases benefit from adjuvant chemotherapy.
The French company's eyonis LCS tool was cleared by the FDA earlier this year to flag lung nodules on low-dose CT scans.
Nature Medicine study suggests transcriptomics-based model could improve patient selection.
Researchers have developed machine learning algorithms that can detect exacerbations from voice changes up to three days before symptoms appear.
The National Institutes of Health-funded study lays the groundwork for a new kind of blood-based test that could potentially predict symptom onset.
Conference News
New Full Text Report Configurability and Six Scientific Presentations at the 21st Annual Scientific Meeting of the Society of Cardiovascular Computed TomographyDENVER--(BUSINESS WIRE)-- Cleerly, a lea...
AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)-- BrainCheck Inc., a cognitive workflow platform, today announced that three of its research submissions have been accepted for poster presentations at the 20...
eMTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer’s diseaseImmunoassay for eM...
CE-marked Access p-Tau217 blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline across EuropeBrain Derived pTau217 RUO assay ...
Five oral presentations in a Featured Research Session will highlight trontinemab, including new long-term data from Phase Ib/IIa Brainshuttle AD study and design of Phase III PrevenTRON study in prec...
